More recently, a comprehensive predictive model for ICB response was developed across 16 different cancer types, which included the features of peripheral blood such as platelets, neutrophil-to-lymphocyte ratio, albumin, and hemoglobin (HGB) (64). The gene discussed is ALB; the disease is cancer.